Skip to main content
. 2021 Mar 1;17(4):957–971. doi: 10.7150/ijbs.52591

Figure 2.

Figure 2

Expression and clinical significance of PRSS1 in GC. (A) Western blotting was performed to detect the expression of PRSS1, HSP90α/β, TGM2, SerpinA3 and P180 in purified NGM, AH, GPDAC and LMGAC tissues. (B) PRSS1 was highly expressed in GC cells. (C) Immunohistochemical staining analysis indicated that PRSS1 was highly expressed in tissues. (D) Patients with high expression of PRSS1 had poor overall survival. GC, gastric cancer; SD, standard deviation. Data are shown as the means ± SD. *P<0.05, **P<0.01, ***P<0.001.